Internal Medicine, Medical Oncology · Vidalia, GA
NPI
1437199965
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
1 Meadows Pkwy Ste B
Vidalia, GA, 30474
Phone (912) 454-7012
Groups this clinician bills Medicare through
Medicare paid, 2024
$5.1M
215,954 services
Medicare patients, 2024
707
Average age 74
Drug cost, 2024
$6.9M
2,153 prescriptions
Company payments, 2025
$16K
From 45 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sreekanth Reddy was code J9299 (injection, nivolumab, 1 mg), 33,120 times for 15 patients. In total Sreekanth Reddy billed 215,954 services in 156 codes, and Medicare paid $5.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9299 Injection, nivolumab, 1 mg | Office | 33,120 | 15 | $24.67 | $817K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 25,300 | 32 | $44.66 | $1.1M |
| J9177 Injection, enfortumab vedotin-ejfv, 0.25 mg | Office | 23,660 | 12 | $28.60 | $677K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 17,500 | 13 | $0.06 | $986 |
| J0185 Injection, aprepitant, 1 mg | Office | 11,050 | 24 | $1.34 | $15K |
| J0897 Injection, denosumab, 1 mg | Office | 6,480 | 43 | $20.29 | $132K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 2,200 | 20 | $16.20 | $36K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,993 | 48 | $0.09 | $180 |
| 85025 Blood Count | Office | 1,785 | 580 | $7.56 | $14K |
| 99214 Office E&M - Established | Office | 1,614 | 488 | $93.85 | $151K |
| 36415 Venipuncture Blood Collection | Office | 1,568 | 599 | $8.59 | $13K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,500 | 39 | $0.71 | $1,067 |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 845 | 15 | $3.64 | $3,074 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 732 | 23 | $0.07 | $54.25 |
| J9190 Injection, fluorouracil, 500 mg | Office | 613 | 17 | $2.32 | $1,424 |
By year: 2022 $1.2M for 65,633 services; 2023 $3.7M for 183,480 services; 2024 $5.1M for 215,954 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,785 | 580 | $7.56 | $14K |
| 36415 Venipuncture Blood Collection | 1,568 | 599 | $8.59 | $13K |
| 80053 Clinical Chemistry | 185 | 109 | $10.29 | $1,904 |
| 84443 Clinical Chemistry | 58 | 37 | $16.46 | $955 |
| 81002 Clinical Chemistry | 55 | 41 | $3.18 | $175 |
| 82728 Clinical Chemistry | 54 | 48 | $13.36 | $721 |
| 83883 Clinical Chemistry | 49 | 20 | $13.33 | $653 |
| 83540 Clinical Chemistry | 47 | 43 | $6.34 | $298 |
| 84466 Clinical Chemistry | 42 | 39 | $12.50 | $525 |
| 82607 Clinical Chemistry | 41 | 37 | $14.78 | $606 |
Medicare prescription drug claims, 2024
In 2024, the drug Sreekanth Reddy prescribed most often to Medicare patients was Anastrozole, with 158 prescriptions and refills. In total Sreekanth Reddy wrote 2,153 Medicare prescriptions that cost $6.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 158 | 246 | 41 | $2,121 |
| Eliquis Apixaban | 137 | 154 | 30 | $87K |
| Oxycodone Hcl Generic | 123 | 124 | 41 | $2,843 |
| Revlimid Lenalidomide | 97 | 97 | 18 | $1.5M |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 74 | 74 | 27 | $2,257 |
| Prednisone Generic | 74 | 77 | 30 | $340 |
| Hydrocortisone Generic | 72 | 76 | 19 | $1,783 |
| Xtandi Enzalutamide | 63 | 63 | 12 | $813K |
| Letrozole Generic | 61 | 97 | 12 | $1,085 |
| Imbruvica Ibrutinib | 61 | 61 | Under 11 | $970K |
| Ondansetron Odt Ondansetron | 58 | 58 | 35 | $2,267 |
| Hydroxyurea Generic | 56 | 84 | 15 | $652 |
| Acyclovir Generic | 45 | 49 | 11 | $547 |
| Dexamethasone Generic | 41 | 52 | 22 | $1,131 |
| Tamoxifen Citrate Generic | 41 | 57 | Under 11 | $1,047 |
Brand drugs: 714 claims; generic drugs: 1,439 claims; opioid claims: 302.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sreekanth Reddy $16K ($16K in general payments such as food, travel and fees) from 45 companies. The largest payer was Pfizer Inc. with $5,837.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 28 | $5,837 |
| Pharmacosmos Therapeutics Inc. | 5 | $5,254 |
| Avyxa Pharma, LLC | 1 | $1,000 |
| Merck Sharp & Dohme LLC MRK | 12 | $355 |
| Celgene Corporation BMY | 14 | $319 |
| Janssen Biotech, Inc. JNJ | 5 | $244 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 7 | $235 |
| Novartis Pharmaceuticals Corporation NVS | 12 | $225 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $209 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 7 | $187 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.